An2 Therapeutics, INC. (ANTX) — 10-K/A Filings
All 10-K/A filings from An2 Therapeutics, INC.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
AN2 Therapeutics Files Amendment No. 1 to Annual Report on Form 10-K
— May 14, 2024 Risk: low
AN2 Therapeutics, Inc. (ANTX) filed a Amended Annual Report (10-K/A) with the SEC on May 14, 2024. AN2 Therapeutics, Inc. filed an amendment (10-K/A) to its ann
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX